We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$9.24B
AUM Growth
-$1.25B
Cap. Flow
-$1.2B
Cap. Flow %
-12.98%
Top 10 Hldgs %
20.23%
Holding
1,512
New
702
Increased
135
Reduced
143
Closed
389

Sector Composition

Rank Sector Weight
1 Healthcare 6.29%
2 Consumer Discretionary 4.04%
3 Technology 3.95%
4 Communication Services 3.85%
5 Financials 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAI icon
1001
CALL
FTAI Aviation
FTAI
$22.8B
$285K ﹤0.01%
+11,827
New +$265K
KEYS icon
1002
Keysight
KEYS
$58.3B
$280K ﹤0.01%
+1,950
New +$277K
CURI icon
1003
CuriosityStream
CURI
$156M
$278K ﹤0.01%
+20,500
New +$355K
BLDP
1004
Ballard Power Systems
BLDP
$826M
$276K ﹤0.01%
+11,356
New +$339K
ADBE icon
1005
Adobe
ADBE
$102B
$275K ﹤0.01%
+579
New +$271K
RXDX
1006
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$274K ﹤0.01%
+15,000
New +$310K
BNS icon
1007
Scotiabank
BNS
$106B
$272K ﹤0.01%
+4,342
New +$252K
GOTU icon
1008
CALL
Gaotu Techedu
GOTU
$448M
$268K ﹤0.01%
+7,900
New +$643K
NVDA icon
1009
NVIDIA
NVDA
$5.13T
$258K ﹤0.01%
+19,320
New +$260K
SWBK.U
1010
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
$255K ﹤0.01%
+25,000
New +$289K
BCRX icon
1011
CALL
BioCryst Pharmaceuticals
BCRX
$2.29B
$254K ﹤0.01%
+25,000
New +$258K
GLHAU
1012
DELISTED
Glass Houses Acquisition Corp. Unit
GLHAU
$251K ﹤0.01%
+25,000
New +$250K
PRPC.U
1013
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$250K ﹤0.01%
+25,000
New +$258K
THMAU
1014
DELISTED
Thimble Point Acquisition Corp. Unit
THMAU
$250K ﹤0.01%
+25,000
New +$255K
TRCA.U
1015
DELISTED
Twin Ridge Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TRCA.U
$249K ﹤0.01%
+25,000
New +$249K
GLBLU
1016
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$249K ﹤0.01%
+25,000
New +$250K
NRDY icon
1017
Nerdy
NRDY
$107M
$248K ﹤0.01%
+25,000
New +$272K
CFVIU
1018
DELISTED
CF Acquisition Corp. VI Unit
CFVIU
$248K ﹤0.01%
+25,000
New +$253K
FSNB.U
1019
DELISTED
Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
FSNB.U
$248K ﹤0.01%
+25,000
New +$249K
IBER.U
1020
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$247K ﹤0.01%
+25,000
New +$250K
AGAC.U
1021
DELISTED
African Gold Acquisition Corp Units
AGAC.U
$247K ﹤0.01%
+25,000
New +$249K
CHFW.U
1022
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$244K ﹤0.01%
25,000
QCOM icon
1023
Qualcomm
QCOM
$171B
$241K ﹤0.01%
1,815
-5,985
-77% -$863K
IBM icon
1024
IBM
IBM
$222B
$240K ﹤0.01%
+1,883
New +$225K
MAT icon
1025
Mattel
MAT
$4.32B
$239K ﹤0.01%
12,000
+332
+3% +$6.42K

Similar funds

CAAS Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, CAAS Capital Management held 1,512 positions worth $9.24B, down 12% from $10.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

CAAS Capital Management withdrew a net $1.2B in Q1 2021, closing 389 positions and reducing 143 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $178M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, up from 6.2% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, CAAS Capital Management opened a new position in Gaotu Techedu worth $30.1M.

  • CAAS Capital Management's largest Q1 2021 buy was Gaotu Techedu: 888,365 shares worth $30.1M.
  • CAAS Capital Management added most to Vipshop in Q1 2021, an estimated $87.6M increase.
  • CAAS Capital Management's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $120M.
  • CAAS Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $178M.
  • CAAS Capital Management's ten largest holdings make up 20% of its $9.24B portfolio in Q1 2021.
  • CAAS Capital Management opened 702 new positions and closed 389 in Q1 2021.
  • CAAS Capital Management's portfolio value fell 12% quarter-over-quarter to $9.24B.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.